Business
Picard Medical / SynCardia to Present Webinar on the Emperor Fully Implantable Total Artificial Heart Hosted by DeviceTalks
TUCSON, Ariz., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that Matt Schuster, Chief Operating Officer, will present an update on the Company’s fully implantable total artificial heart technology as part of the DeviceTalks Tuesdays webcast series hosted by DeviceTalks. During the se
About this update from Picard Medical, Inc.
[{"type":"image","alt":"Picard Medical, Inc.","displaySize":"","headline":null,"caption":"Picard Medical, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":75,"url":"https://media.zenfs.com/en/globenewswire.com/4e25733b249cfcdd029f5354275c291a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gcgpu3t6z4ZWVpSIwIEbWQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/4e25733b249cfcdd029f5354275c291a","width":300,"height":75}},"lazy":false},{"type":"text","content":"TUCSON, Ariz., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that Matt Schuster, Chief Operating Officer, will present an update on the Company’s fully implantable total artificial heart technology as part of the DeviceTalks Tuesdays webcast series hosted by DeviceTalks.","length":486,"tagName":"p"},{"type":"text","content":"During the session, Mr. Schuster will review preclinical experience with SynCardia’s next-generation, fully implantable total artificial heart platform, Emperor. The presentation will include bench and acute in vivo data, with emphasis on hemodynamic performance, robustness, physiological responsiveness, and system stability. The session will also feature a personal perspective from Mr. Schuster on how his multidisciplinary background and experience contributed to the development of the Emperor platform, offering insight intended to inspire innovation across the medical device community.","length":594,"tagName":"p"},{"type":"text","content":"Details of the webinar are below:","length":33,"tagName":"p"},{"type":"text","content":"Title: The Emperor: A Fully Implantable, Mechanically Driven Next-Generation SynCardia Total Artificial Heart Date: February 3rd, 2026Time: 12:00pm ETHost: DeviceTalks — DeviceTalks Tuesdays Webcast SeriesFormat: Live virtual webinarRegistration: Click here to register","length":274,"tagName":"p","attribs":{}},{"type":"text","content":"The webcast will be available for download and streaming on all major platforms, including Apple Podcasts, Spotify, and Google Podcasts and available directly on DeviceTalks Tuesday’s website here.","length":197,"tagName":...